hummm,,,so a question to the board,,,,,,what type of deal is going to refund the Third Eye come May/2019 after we have successful BoM top line results later this year??...DM will have to make a deal with some entity in some form or fashion!!,,,,I am thinking Eastern would position itself again to some degree!,,I dont know if they would want to pay dearly when they could get in on the cheap side of the BoM milestone!,,,,it must be assumed that Eastern will have to break their silence sooner rather then later unless a back room deal is under a gentleman's agreement and sealed with a handshake. Based on the tracks in the sand Eastern is not in our sandbox presently. Its a point to ponder imo,,,we already assume that the CKD and Fabry have to get going before any data comes back from the BoM trial............that is imperative if BoM results are weak so RVX can carry on in limp mode until data from the other trials are available!,,,,,Perhaps the deep pocketed sideliner/s are more willing to pay dearly than to buy this risk on the cheap!!,,if blockbuster is in fact a fair statement around 208 then whats' to lose by BP or other buying in much later after the data milestone, even after May/2019!!,,,just thinking.